Page last updated: 2024-10-25

deferoxamine and Bile Duct Obstruction, Intrahepatic

deferoxamine has been researched along with Bile Duct Obstruction, Intrahepatic in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yilmaz, S1
Duman, N1
Ozer, E2
Kavas, N1
Oren, H1
Demircioğlu, F1
Kumral, A1
Ozkan, H1
Irken, G1

Other Studies

1 other study available for deferoxamine and Bile Duct Obstruction, Intrahepatic

ArticleYear
A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:5

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Cholestasis, Intrahepatic; Deferoxamine; Female; Humans; Infan

2006